Ocular Therapeutix Inc. logo

Ocular Therapeutix Inc.

OCUL | NASDAQ
Chart Builder DCF Calculator
$6.74
-$0.23 (-3.30%)
Nov 2, 2026, 12:40 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-265.94M -193.51M -80.74M -71.04M -6.55M -155.64M
Depreciation & Amortization
4.32M 3.79M 2.98M 2.11M 2.42M 2.77M
Stock-Based Compensation
43.18M 33.11M 17.83M 16.96M 14.98M 7.53M
Other Working Capital
7.38M -2.97M -2.81M 2.88M 4.24M 11.58M
Other Non-Cash Items
5.84M 32.16M -2.9M -8.99M -73.49M 4.41M
Deferred Income Tax
n/a n/a n/a n/a n/a 86.19M
Change in Working Capital
7.71M -10.23M -7.41M 1.35M -2.9M 1.18M
Operating Cash Flow
-204.88M -134.68M -70.23M -59.6M -65.55M -53.55M
Capital Expenditures
-12.01M -1.29M -6.09M -3.72M -1.19M -841K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
130K n/a n/a n/a n/a n/a
Investing Cash Flow
-11.88M -1.29M -6.09M -3.72M -1.19M -841K
Debt Repayment
n/a 316.35M 56.35M n/a -445K n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -300.6M -4.63M 514K 2.31M 3.33M
Financial Cash Flow
561.72M 332.11M 169.83M 1.45M 2.85M 228.01M
Net Cash Flow
344.96M 196.15M 93.51M -61.86M -63.89M 173.62M
Free Cash Flow
-216.89M -135.97M -76.32M -63.32M -66.74M -54.4M
Adj. Free Cash Flow
-260.08M -169.07M -94.15M -80.28M -81.72M -61.93M
Maintenance CapEx
-12.01M n/a -2.23M n/a n/a n/a
Growth CapEx
n/a -1.29M -3.86M -3.72M -1.19M -841K
Owner Earnings
-216.89M -134.68M -72.46M -59.6M -65.55M -53.55M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.